Vanguard Personalized Indexing Management, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 21,123 shares of AMLX stock, worth $172,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,123
Previous 21,756
2.91%
Holding current value
$172,152
Previous $77,000
75.32%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AMLX
# of Institutions
149Shares Held
71.1MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$64.2 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$48.4 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$46.4 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$33.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.08MShares$25.1 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $477M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...